Front & Back Matter.
- Published in:
- Nephron, 2023, v. 147, n. 2, p. 1, doi. 10.1159/000530244
- Publication type:
- Article
Works matching IS 16608151 AND DT 2023 AND VI 147 AND IP 2
Results: 8
1
2
Can the Use of Continuous Glucose Monitoring Improve Glycemic Control in Patients with Type 1 and 2 Diabetes Receiving Dialysis?
- Published in:
- Nephron, 2023, v. 147, n. 2, p. 91, doi. 10.1159/000525676
- By:
- Publication type:
- Article
3
ANCA-Associated Vasculitis following the First Dose of Pfizer-BioNTech COVID-19 Vaccine.
- Published in:
- Nephron, 2023, v. 147, n. 2, p. 103, doi. 10.1159/000525562
- By:
- Publication type:
- Article
4
Facing the Challenge of Drug-Induced Acute Interstitial Nephritis.
- Published in:
- Nephron, 2023, v. 147, n. 2, p. 78, doi. 10.1159/000525561
- By:
- Publication type:
- Article
5
DPP4 Inhibitor-Induced Bullous Pemphigoid in Patients with Diabetes and Chronic Kidney Disease: Clinical Case Series.
- Published in:
- Nephron, 2023, v. 147, n. 2, p. 97, doi. 10.1159/000525520
- By:
- Publication type:
- Article
6
MicroRNA-155-5p Aggravates Adriamycin-Induced Focal Segmental Glomerulosclerosis through Targeting Nrf2.
- Published in:
- Nephron, 2023, v. 147, n. 2, p. 108, doi. 10.1159/000525233
- By:
- Publication type:
- Article
7
Onconephrology: Update in Anticancer Drug-Related Nephrotoxicity.
- Published in:
- Nephron, 2023, v. 147, n. 2, p. 65, doi. 10.1159/000525029
- By:
- Publication type:
- Article
8
PAX2/Renal Coloboma Syndrome Expresses Extreme Intrafamilial Phenotypic Variability.
- Published in:
- Nephron, 2023, v. 147, n. 2, p. 120, doi. 10.1159/000525022
- By:
- Publication type:
- Article